ArticleJCO precision oncology2024

Influence of Epithelial-Mesenchymal Transition on Risk of Relapse and Outcome to Eribulin or Cyclin-Dependent Kinase Inhibitors in Metastatic Breast Cancer.

Arlene Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.